Suprefact Depot
Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Buserelin acetate 6.6mg equivalent to 6.3 mg of buserelin
Available from:
sanofi-aventis new zealand limited
INN (International Name):
Buserelin acetate 6.6 mg (equivalent to 6.3 mg of buserelin)
Dosage:
6.3 mg
Pharmaceutical form:
Subcutaneous implant
Composition:
Active: Buserelin acetate 6.6mg equivalent to 6.3 mg of buserelin Excipient: Polyglactin
Units in package:
Bag, plastic, trilaminate, 1 implant
Class:
Prescription
Prescription type:
Prescription
Manufactured by:
Sanofi-Aventis Deutschland GmbH
Product summary:
Package - Contents - Shelf Life: Bag, plastic, trilaminate - 1 implants - 3 years from date of manufacture stored at or below 30°C
Authorization date:
1998-10-22
